RSV Immunisation Update: Inclusion of Catchup Cohort and New Developments
In this episode, Sheena explains the recent updates on the RSV immunisation program in Ireland. Last year, the monoclonal antibody called Nirsevimab was offered to babies born between September 1st and February 28th, providing protection against the respiratory syncytial virus (RSV). This year, the program has expanded to include a catchup cohort of babies born from March 1st to August 31st, addressing concerns from parents whose babies missed out previously. Sheena highlights the significance of this development, the benefits of the immunisation, and the impact on reducing hospitalisations. Additional high-risk infants are also included in the updated plan. The episode covers the details of the program, eligibility criteria, and Sheena’s efforts to seek clarity on the rollout schedule.
00:00 Introduction and Host Background
00:11 RSV Immunisation Update
01:58 Understanding RSV
02:49 Last Year's Immunisation Program
07:31 New Immunisation Plan for This Year
08:19 Eligibility and Implementation Details
11:54 Conclusion and Upcoming Podcast Topics
Follow Sheena on Instagram - https://www.instagram.com/wondercare_irl
#rsv #rsvimmunisation #respiratorysynctialvirus #respiratoryhealth #nirsevimab #infectiousdisease #immunisationrates #vaccinereality #irishhealth #irishhealthcare #pharmacist #patientadvocate #sheenamitchell #healthcare #healthcarepodcast #healthtips #preventativehealth #healthsystem #rsvcatchup #rsvcatchupprogramme #nirsevimab
","author_name":"WonderCare"}